Prevention of type 2 diabetes through lifestyle modification: Is there a role for higher-protein diets?

Advances in Nutrition

Volumn 6, Issue 6, 2015, Pages 665-673

  Liu, Amy Y ^a   Silvestre, Marta P ^a   Poppitt, Sally D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Carbohydrate; Dietary protein; Fat; Lifestyle modification; Obesity; Prediabetes; T2D

Indexed keywords

GLUCOSE BLOOD LEVEL; PROTEIN INTAKE;

ADMINISTRATION AND DOSAGE; ADULT; AGED; ANALYSIS; BODY COMPOSITION; CALORIC INTAKE; CHINA; DIABETES MELLITUS, TYPE 2; DIET; DIET THERAPY; EXERCISE; FEMALE; FINLAND; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; PROTEIN INTAKE; UNITED STATES; WEIGHT REDUCTION;

ADULT; AGED; APPETITE REGULATION; BLOOD GLUCOSE; BODY COMPOSITION; CHINA; DIABETES MELLITUS, TYPE 2; DIET; DIETARY PROTEINS; ENERGY INTAKE; EXERCISE; FEMALE; FINLAND; HUMANS; INDIA; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; UNITED STATES; WEIGHT LOSS;

EID: 84953268538     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.008821     Document Type: Review

References (116)

1. Backholer K, Peeters A, Herman WH, Shaw JE, Liew D, Ademi Z,Magliano DJ. Diabetes prevention and treatment strategies: Are wedoing enough? Diabetes Care 2013;36:2714-9.
2. Alberti KG, Zimmet PZ. Diabetes: A look to the future. Lancet DiabetesEndocrinol 2014;2:e1-2.
3. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C,Williams DE, Gregg EW, Bainbridge KE, Saydah SH, et al. Full accountingof diabetes and pre-diabetes in the US population in1988-1994 and 2005-2006. Diabetes Care 2009;32:287-94.
4. International Diabetes Federation Diabetes Atlas: International DiabetesFederation [Internet]. 2013 [cited 2015 Feb 21.] Available from:www.idf. org/diabetesatlas/.
5. Coppell KJ, Mann JI, Williams SM, Jo E, Drury PL, Miller JC, ParnellWR. Prevalence of diagnosed and undiagnosed diabetes and prediabetesin New Zealand: Findings from the 2008/09 adult nutrition survey.N Z Med J 2013;126:23-42.
6. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U,Shaw JE. Global estimates of diabetes prevalence for 2013 and projectionsfor 2035 for the IDF diabetes atlas. Diabetes Res Clin Pract 2014;103:137-49.
7. Pan XR, Yang WY, Li GW, Liu J. National Diabetes Prevention andControl Cooperative Group. Prevalence of diabetes and its risk factorsin China. Diabetes Care 1997;20:1664-9.
8. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: A 21stcentury challenge. Lancet Diabetes Endocrinol 2014;2:56-64.
9. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013;36:1033-46.
10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J,Xiao JZ, Cao HB, et al. Effects of diet and exercise in preventingNIDDM in people with impaired glucose tolerance: The Da QingIGT and diabetes study. Diabetes Care 1997;20:537-44.
11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H,Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, LouherantaA, Rastas M, et al. Prevention of type 2 diabetes mellitus by changesin lifestyle among subjects with impaired glucose tolerance. N EnglJ Med 2001;344:1343-50.
12. Khavandi K, Amer H, Ibrahim B, Brownrigg J. Strategies for preventingtype 2 diabetes: An update for clinicians. Ther Adv Chronic Dis2013;4:242-61.
13. Ferrannini E. Definition of intervention points in prediabetes. LancetDiabetes Endocrinol 2014;2:667-75.
14. American Diabetes AssociationStandards of medical care in diabetes 2014. Diabetes Care 2014;37:S14-80.
15. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, DelahantyL, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, et al. Effect ofweight loss with lifestyle intervention on risk of diabetes. DiabetesCare 2006;29:2102-7.
16. Diabetes Prevention Program (DPP) Research Group. The diabetesprevention program (DPP): Description of lifestyle intervention. DiabetesCare 2002;25:2165-71.
17. Alibasic E, Ramic E, Alic A. Prevention of diabetes in family medicine.Mater Sociomed 2013;25:80-2.
18. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT,Khunti K. Pharmacological and lifestyle interventions to prevent ordelay type 2 diabetes in people with impaired glucose tolerance: Systematicreview and meta-analysis. BMJ 2007;334:299.
19. Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH,Blaak EE. Impact of 3-year lifestyle intervention on postprandialglucose metabolism: The SLIM study. Diabet Med 2008;25:597-605.
20. Eriksson KF, Lindgärde F. Prevention of type 2 (non-insulin-dependent)diabetes mellitus by diet and physical exercise. the 6-year Malmö feasibilitystudy. Diabetologia 1991;34:891-8.
21. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, JiangY, An Y, et al. The long-term effect of lifestyle interventions to preventdiabetes in the China Da Qing diabetes prevention study: A 20-yearfollow-up study. Lancet 2008;371:1783-9.
22. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V,Eriksson J, Uusitupa M, Tuomilehto J. The Finnish diabetes preventionstudy (DPS) lifestyle intervention and 3-year results on dietand physical activity. Diabetes Care 2003;26:3230-6.
23. Penn L, White M, Lindstrom J, den Boer AT, Blaak E, Eriksson JG,Feskens E, Ilanne-Parikka P, Keinanen-Kiukaanniemi SM, WalkerM, et al. Importance of weight loss maintenance and risk predictionin the prevention of type 2 diabetes: Analysis of European diabetesprevention study RCT. PLoS ONE. 2013 Article Number: e5;8(2):e57143.
24. Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. Preventionof type 2 diabetes in adults with impaired glucose tolerance:The European diabetes prevention RCT in Newcastle upon Tyne,UK. BMC Public Health 2009;9:342.
25. Sakane N. Japan diabetes prevention program. Nippon Rinsho 2005;63: Suppl.2:488-92.
26. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedfordsurvey (1962-1972): Glucose tolerance and diabetes. Diabetologia1982;22:73-8.
27. Keen H, Jarrett RJ, Ward JD, Fuller JH. Borderline diabetics and theirresponse to tolbutamide. Adv Metab Disord 1973;2:Suppl 2:521-31.
28. Jarrett RJ, Keen H, McCartney P. The Whitehall study: Ten yearfollow-up report on men with impaired glucose tolerance with referenceto worsening to diabetes and predictors of death. Diabet Med1984;1:279-83.
29. Eriksson KF, Lindgärde F. No excess 12-year mortality in men withimpaired glucose tolerance who participated in the Malmö preventivetrial with diet and exercise. Diabetologia 1998;41:1010-6.
30. Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B,Shuai Y, Hong J, et al. Cardiovascular mortality, all-cause mortality,and diabetes incidence after lifestyle intervention for people with impairedglucose tolerance in the Da Qing diabetes prevention study: A23-year follow-up study. Lancet Diabetes Endocrinol 2014;2:474-80.
31. Wein P, Beischer N, Harris C, Permezel M. A trial of simple versus intensifieddietary modification for prevention of progression to diabetesmellitus in women with impaired glucose tolerance. Aust N Z JObstet Gynaecol 1999;39:162-6.
32. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyleintervention: A Japanese trial in IGT males. Diabetes Res ClinPract 2005;67:152-62.
33. Page RC, Harnden KE, Cook JT, Turner RC. Can life-styles of subjectswith impaired glucose tolerance be changed? A feasibility study. DiabetMed 1992;9:562-6.
34. Bourn DM, Mann JI, McSkimming BJ, Waldron MA, Wishart JD. Impairedglucose tolerance and NIDDM: Does a lifestyle interventionprogram have an effect? Diabetes Care 1994;17:1311-9.
35. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG,Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S,Laakso M, et al. Sustained reduction in the incidence of type 2 diabetesby lifestyle intervention: Follow-up of the Finnish diabetes preventionstudy. Lancet 2006;368:1673-9.
36. Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S,Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. Finnish DiabetesPrevention Study (DPS). Improved lifestyle and decreased diabetesrisk over 13 years: Long-term follow-up of the randomised Finnish diabetesprevention study (DPS). Diabetologia 2013;56:284-93.
37. UusitupaM, Lindi V, Louheranta A, Salopuro T, LindströmJ, TuomilehtoJ. Finnish Diabetes Prevention Study Group. Long-term improvement ininsulin sensitivity by changing lifestyles of people with impaired glucosetolerance: 4-year results from the Finnish diabetes preventionstudy. Diabetes 2003;52:2532-8.
38. Lindström J, Tuomilehto J. The diabetes risk score: A practical tool topredict type 2 diabetes risk. Diabetes Care 2003;26:725-31.
39. Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H,Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, TuomilehtoJ. Finnish Diabetes Prevention Study (DPS) Group. Determinants forthe effectiveness of lifestyle intervention in the Finnish Diabetes PreventionStudy. Diabetes Care. 2008;31(5):857-62.
40. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM,Walker EA, Nathan DM, Diabetes Prevention Program ResearchGroup. Reduction in the incidence of type 2 diabetes with lifestyle interventionor metformin. N Engl J Med 2002;346:393-403.
41. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA,Haffner SM, Hoskin M, Nathan DM. The prevention of type 2 diabetes.Nat Clin Pract Endocrinol Metab 2008;4:382-93.
42. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ,Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, NathanDM. 10-year follow-up of diabetes incidence and weight loss in thediabetes prevention program outcomes study. Lancet 2009;374:1677-86.
43. Nathan DM, Knowler WC, Fowler SE, Hamman RF, Hoffman HJ,Brenneman AT, Goldberg R, Venditti E. In: Results from the diabetesprevention program outcomes study: 1996-2013 American Diabetes Association74th Scientific Symposium, San Francisco, USA. June 13-17, 2014.
44. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD,Vijay V. The Indian diabetes prevention programme shows that lifestylemodification and metformin prevent type 2 diabetes in AsianIndian subjects with impaired glucose tolerance (IDPP-1). Diabetologia2006;49:289-97.
45. Mensink M, Feskens EJ, Saris WJ, De Bruin TW, Blaak EE. Study onlifestyle intervention and impaired glucose tolerance Maastricht(SLIM): Preliminary results after one year. Int J Obes Relat Metab Disord2003;27:377-84.
46. Roumen C, Feskens EJ, Corpeleijn E, Mensink M, Saris WH, BlaakEE. Predictors of lifestyle intervention outcome and dropout: TheSLIM study. Eur J Clin Nutr 2011;65:1141-7.
47. Liao D, Asberry PJ, Shofer JB, Callahan H, Matthys C, Boyko EJ,Leonetti D, Kahn SE, Austin M, Newell L, et al. Improvement ofBMI, body composition, and body fat distribution with lifestylemodification in Japanese Americans with impaired glucose tolerance.Diabetes Care 2002;25:1504-10.
48. Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T,Fukunaga R, Bandai Y, Tajima N, Nakamura Y. Lifestyle modificationand prevention of type 2 diabetes in overweight Japanese with impairedfasting glucose levels: A randomized controlled trial. Arch InternMed 2011;171:1352-60.
49. Tao L, Deng Y, Fan X, Bao Q. [Effect of exercise training in patientswith impaired glucose tolerance] Zhongguo Linchuang Kangfu. 2004;8:2912-3.
50. Fang Y, Li T, Chen S. [Effect of medicine and non-medicine interventionon the outcomes of patients with impaired glucose tolerance:5-year follow-up] Zhongguo Linchuang Kangfu. 2004;8:6562-3.
51. Uusitupa M. Lifestyles matter in the prevention of type 2 diabetes. DiabetesCare 2002;25:1650-1.
52. Noakes M. The role of protein in weight management. Asia Pac J ClinNutr 2008;17: Suppl 1:169-71.
53. Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A,Westerterp-Plantenga M. Protein, weight management, and satiety.Am J Clin Nutr 2008;87:1558S-61S.
54. Gilbert JA, Bendsen NT, Tremblay A, Astrup A. Effect of proteinsfrom different sources on body composition. Nutr Metab CardiovascDis 2011;21: Suppl 2:B16-31.
55. Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, PfeifferAF, Martinez JA, Handjieva-Darlenska T, Kune sová M, Pihlsgård M,et al. Diets with high or low protein content and glycemic index forweight-loss maintenance. N Engl J Med 2010;363:2102-13.
56. Morenga LT, Williams S, Brown R, Mann J. Effect of a relatively highprotein,high-fiber diet on body composition and metabolic risk factorsin overweight women. Eur J Clin Nutr 2010;64:1323-31.
57. Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE.Effects of a high-protein ketogenic diet on hunger, appetite, and weightloss in obese men feeding ad libitum. Am J Clin Nutr 2008;87:44-55.
58. Johnstone AM, Lobley GE, Horgan GW, Bremner DM, Fyfe CL,Morrice PC, Duthie GG. Effects of a high-protein, low-carbohydratev. high-protein, moderate-carbohydrate weight-loss diet on antioxidantstatus, endothelial markers and plasma indices of the cardiometabolicprofile. Br J Nutr 2011;106:282-91.
59. Clifton PM, Condo D, Keogh JB. Long term weight maintenance afteradvice to consume low carbohydrate, higher protein diets-a systematicreview and meta analysis. Nutr Metab Cardiovasc Dis 2014;24:224-35.
60. Clifton PM, Keogh JB, Noakes M. Long-term effects of a high-proteinweight-loss diet. Am J Clin Nutr 2008;87:23-9.
61. Dong JY, Zhang ZL,Wang PY, Qin LQ. Effects of high-protein diets onbody weight, glycaemic control, blood lipids and blood pressure intype 2 diabetes: Meta-analysis of randomised controlled trials. Br JNutr 2013;110:781-9.
62. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD,McManus K, Champagne CM, Bishop LM, Laranjo N, et al. Comparisonof weight-loss diets with different compositions of fat, protein,and carbohydrates. N Engl J Med 2009;360:859-73.
63. Liebman M. When and why carbohydrate restriction can be a viableoption. Nutrition 2014;30:748-54.
64. Foster GD,Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS,Szapary PO, Rader DJ, Edman JS, Klein S. A randomized trial of alow-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-90.
65. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR,Kraemer HC, King AC. Comparison of the Atkins, Zone, Ornish,and LEARN diets for change in weight and related risk factors amongoverweight premenopausal women: The A TO Z weight loss study: Arandomized trial. JAMA 2007;297:969-77.
66. Bazzano LA, Hu T, Reynolds K, Yao L, Bunol C, Liu Y, Chen CS, KlagMJ, Whelton PK, He J. Effects of low-carbohydrate and low-fat diets:A randomized trial. Ann Intern Med 2014;161:309-18.
67. Soenen S, Bonomi AG, Lemmens SG, Scholte J, Thijssen MA, vanBerkum F, Westerterp-Plantenga MS. Relatively high-protein or'low-carb'energy-restricted diets for body weight loss and body weightmaintenance? Physiol Behav 2012;107:374-80.
68. Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ,Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, et al.Dietary carbohydrate restriction as the first approach in diabetes management:Critical review and evidence base. Nutrition 2015;31:1-13.
69. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J,Williams T, Williams M, Gracely EJ, Stern L. A low-carbohydrate ascompared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074-81.
70. Fogelholm M, Larsen TM, Westerterp-Plantenga M, Macdonald I,Martinez J, Handjiev S, Brand-Miller J, Poppitt S, Schlicht W, StrattonG, et al. The PREVIEW intervention trial: Design and methods. AnnNutr Metab 2013;63:96-7.
71. Westerterp-Plantenga MS, Lejeune MP, Nijs I, Van Ooijen M, KovacsEM. High protein intake sustains weight maintenance after bodyweight loss in humans. Int J Obes Relat Metab Disord 2004;28:57-64.
72. Bowen J, Noakes M, Trenerry C, Clifton PM. Energy intake, ghrelin,and cholecystokinin after different carbohydrate and protein preloadsin overweight men. J Clin Endocrinol Metab 2006;91:1477-83.
73. Barkeling B, Rössner S, Björvell H. Effects of a high-protein meal(meat) and a high-carbohydrate meal (vegetarian) on satiety measuredby automated computerized monitoring of subsequent food intake, motivationto eat and food preferences. Int J Obes 1990;14:743-51.
74. Porrini M, Crovetti R, Testolin G, Silva S. Evaluation of satiety sensationsand food intake after different preloads. Appetite 1995;25:17-30.
75. Anderson GH, Moore SE. Dietary proteins in the regulation of foodintake and body weight in humans. J Nutr 2004;134:974S-9S.
76. Halton TL, Hu FB. The effects of high protein diets on thermogenesis,satiety and weight loss: A critical review. J Am Coll Nutr 2004;23:373-85.
77. Weigle DS, Breen PA, Matthys CC, Callahan HS, Meeuws KE, BurdenVR, Purnell JQ. A high-protein diet induces sustained reductions inappetite, ad libitum caloric intake, and body weight despite compensatorychanges in diurnal plasma leptin and ghrelin concentrations.Am J Clin Nutr 2005;82:41-8.
78. Poppitt SD, McCormack D, Buffenstein R. Short-term effects of macronutrientpreloads on appetite and energy intake in lean women.Physiol Behav 1998;64:279-85.
79. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A,Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. Effects of high and normal soy protein breakfasts onsatiety and subsequent energy intake, including amino acid and 'satiety'hormone responses. Eur J Nutr 2009;48:92-100.
80. BlomWA, Lluch A, Stafleu A, Vinoy S, Holst JJ, Schaafsma G, HendriksHF. Effect of a high-protein breakfast on the postprandial ghrelin response.Am J Clin Nutr 2006;83:211-20.
81. Bowen J, Noakes M, Clifton PM. Appetite hormones and energy intakein obese men after consumption of fructose, glucose and wheyprotein beverages. Int J Obes (Lond) 2007;31:1696-703.
82. Aldrich ND, Reicks MM, Sibley SD, Redmon JB, ThomasW, Raatz SK.Varying protein source and quantity do not significantly improveweight loss, fat loss, or satiety in reduced energy diets among midlifeadults. Nutr Res 2011;31:104-12.
83. Penhoat A, Mutel E, Amigo-Correig M, Pillot B, Stefanutti A, Rajas F,Mithieux G. Protein-induced satiety is abolished in the absence of intestinalgluconeogenesis. Physiol Behav 2011;105:89-93.
84. Bowen J, Noakes M, Clifton PM. Appetite regulatory hormone responsesto various dietary proteins differ by body mass index statusdespite similar reductions in ad libitum energy intake. J Clin EndocrinolMetab 2006;91:2913-9.
85. Burton-Freeman BM. Glycomacropeptide (GMP) is not critical towhey-induced satiety, but may have a unique role in energy intakeregulation through cholecystokinin (CCK). Physiol Behav 2008;93:379-87.
86. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exertdifferent effects on plasma amino acid profiles, gastrointestinal hormonesecretion and appetite. Br J Nutr 2003;89:239-48.
87. Anderson GH, Tecimer SN, Shah D, Zafar TA. Protein source, quantity,and time of consumption determine the effect of proteins onshort-term food intake in young men. J Nutr 2004;134:3011-5.
88. Lang V, Bellisle F, Oppert JM, Craplet C, Bornet FR, Slama G, Guy-GrandB. Satiating effect of proteins in healthy subjects: A comparison of eggalbumin, casein, gelatin, soy protein, pea protein, and wheat gluten.Am J Clin Nutr 1998;67:1197-204.
89. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A,Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. Effects of complete whey-protein breakfasts versuswhey without GMP-breakfasts on energy intake and satiety. Appetite2009;52:388-95.
90. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A,Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. A breakfast with alpha-lactalbumin, gelatin, orgelatin +TRP lowers energy intake at lunch compared with a breakfast withcasein, soy, whey, or whey-GMP. Clin Nutr 2009;28:147-55.
91. Poppitt SD, Strik CM, McArdle BH, McGill AT, Hall RS. Evidence ofenhanced serum amino acid profile but not appetite suppression bydietary glycomacropeptide (GMP): A comparison of dairy whey proteins.J Am Coll Nutr 2013;32:177-86.
92. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, vanVughtAJ, Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. Dose-dependent satiating effect of whey relativeto casein or soy. Physiol Behav 2009;96:675-82.
93. de Graaf C, BlomWA, Smeets PA, Stafleu A, Hendriks HF. Biomarkersof satiation and satiety. Am J Clin Nutr 2004;79:946-61.
94. Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH. Effectof protein, fat, carbohydrate and fibre on gastrointestinal peptiderelease in humans. Regul Pept 2008;149:70-8.
95. Fromentin G, Darcel N, Chaumontet C, Marsset-Baglieri A, NadkarniN, Tome D. Peripheral and central mechanisms involved in the controlof food intake by dietary amino acids and proteins. Nutr Res Rev2012;25:29-39.
96. Mars M, Stafleu A, de Graaf C. Use of satiety peptides in assessing thesatiating capacity of foods. Physiol Behav 2012;105:483-8.
97. Kushner RF, Doerfler B. Low-carbohydrate, high-protein diets revisited.Curr Opin Gastroenterol 2008;24:198-203.
98. Astrup A, Rossner S, VanGaal L, Rissanen A, Niskanen L, Al HakimM, Madsen J, Rasmussen MF, Lean ME. Effects of liraglutide in thetreatment of obesity: A randomised, double-blind,placebo-controlledstudy. Lancet 2009;374:1606-16.
99. Josse AR, Atkinson SA, Tarnopolsky MA, Phillips SM. Increased consumptionof dairy foods and protein during diet- and exercise-inducedweight loss promotes fat mass loss and lean mass gain in overweight andobese premenopausal women. J Nutr 2011;141:1626-34.
100. Layman DK, Baum JI. Dietary protein impact on glycemic controlduring weight loss. J Nutr 2004;134:968S-73S.
101. Baum JI, Layman DK, Freund GG, Rahn KA, Nakamura MT, YudellBE. A reduced carbohydrate, increased protein diet stabilizes glycemiccontrol and minimizes adipose tissue glucose disposal in rats. J Nutr2006;136:1855-61.
102. McGregor RA, Poppitt SD. Milk protein for improved metabolichealth: A review of the evidence. Nutr Metab (Lond) 2013;10:46-59.
103. Jakubowicz D, Froy O. Biochemical and metabolic mechanisms bywhich dietary whey protein may combat obesity and type 2 diabetes.J Nutr Biochem 2013;24:1-5.
104. Veldhorst MA, Westerterp KR, Westerterp-Plantenga MS. Gluconeogenesisand protein-induced satiety. Br J Nutr 2012;107:595-600.
105. Jensen KJ, Alpini G, Glaser S. Hepatic nervous system and neurobiologyof the liver. Compr Physiol 2013;3:655-65.
106. Neis EP, Dejong CH, Rensen SS. The role of microbial amino acid metabolismin host metabolism. Nutrients 2015;7:2930-46.
107. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean dietand health. Biofactors 2013;39:335-42.
108. Cope MB, Erdman JJ, Allison DB. The potential role of soyfoods inweight and adiposity reduction: An evidence-based review. ObesRev 2008;9:219-35.
109. Du H, van der A DL, van Bakel M, Slimani N, Forouhi NG, WarehamNJ, Halkjær J, Tjønneland A, Jakobsen MU, Overvad K, et al. Dietaryglycaemic index, glycaemic load and subsequent changes of weightand waist circumference in European men and women. Int J Obes(Lond) 2009;33:1280-8.
110. Halkjær J, Olsen A, Overvad K, Jakobsen MU, Boeing H, Buijsse B,Palli D, Tognon G, Du H, van der A DL, et al. Intake of total, animaland plant protein and subsequent changes in weight or waist circumferencein European men and women: The Diogenes project. Int JObes (Lond) 2011;35:1104-13.
111. Vergnaud AC, Norat T, Romaguera D, Mouw T, May AM, Travier N,Luan J, Wareham N, Slimani N, Rinaldi S, et al. Meat consumptionand prospective weight change in participants of the EPIC-PANACEAstudy. Am J Clin Nutr 2010;92:398-407.
112. Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Willett WC,Hu FB. Red meat consumption and risk of type 2 diabetes: 3 cohortsof US adults and an updated meta-analysis. Am J Clin Nutr 2011;94:1088-96.
113. Pan A, Hu FB. Can eating red meat increase the risk of developingtype 2 diabetes? Diabetes Management 2014;4:1-4.
114. Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Stampfer MJ,Willett WC, Hu FB. Red meat consumption and mortality: Resultsfrom 2 prospective cohort studies. Arch Intern Med 2012;172:555-63.
115. Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW,Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, et al.Low protein intake is associated with a major reduction in IGF-1,cancer, and overall mortality in the 65 and younger but not olderpopulation. Cell Metab 2014;19:407-17.
116. National Academy of Sciences. Institute of Medicine. Food and NutritionBoard. Dietary reference intakes for energy, carbohydrate, fiber,fat, fatty acids, cholesterol, protein and amino acids. National AcademyPress Washington (DC).2005.